[HTML][HTML] Pharmacotherapy of anxiety disorders: current and emerging treatment options

A Garakani, JW Murrough, RC Freire, RP Thom… - Frontiers in …, 2020 - frontiersin.org
Anxiety disorders are the most prevalent psychiatric disorders and a leading cause of
disability. While there continues to be expansive research in posttraumatic stress disorder …

[HTML][HTML] Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders

SB Sartori, N Singewald - Pharmacology & therapeutics, 2019 - Elsevier
Current medication for anxiety disorders is suboptimal in terms of efficiency and tolerability,
highlighting the need for improved drug treatments. In this review an overview of drugs …

Sigma receptors [σ Rs]: biology in normal and diseased states

CG Rousseaux, SF Greene - Journal of Receptors and Signal …, 2016 - Taylor & Francis
This review compares the biological and physiological function of Sigma receptors [σRs] and
their potential therapeutic roles. Sigma receptors are widespread in the central nervous …

GABA receptors: pharmacological potential and pitfalls

M Jazvinscak Jembrek, J Vlainic - Current pharmaceutical …, 2015 - ingentaconnect.com
Gamma-amino butyric acid (GABA), the major inhibitory neurotransmitter in the mammalian
central nervous system, plays a key role in the regulation of neuronal transmission …

[HTML][HTML] Alleviating anxiety and taming trauma: novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder

N Singewald, SB Sartori, A Reif, A Holmes - Neuropharmacology, 2023 - Elsevier
Psychiatric disorders associated with psychological trauma, stress and anxiety are a highly
prevalent and increasing cause of morbidity worldwide. Current therapeutic approaches …

An emerging role for sigma-1 receptors in the treatment of developmental and epileptic encephalopathies

P Martin, T Reeder, J Sourbron, PAM de Witte… - International journal of …, 2021 - mdpi.com
Developmental and epileptic encephalopathies (DEEs) are complex conditions
characterized primarily by seizures associated with neurodevelopmental and motor deficits …

Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment

RY Wong, SE Oxendine, J Godwin - BMC genomics, 2013 - Springer
Background Stress and anxiety-related behaviors are seen in many organisms. Studies
have shown that in humans and other animals, treatment with selective serotonin reuptake …

Translocator protein in the rise and fall of central nervous system neurons

G Cheung, YC Lin, V Papadopoulos - Frontiers in Cellular …, 2023 - frontiersin.org
Translocator protein (TSPO), a 18 kDa protein found in the outer mitochondrial membrane,
has historically been associated with the transport of cholesterol in highly steroidogenic …

5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients

RC Agis-Balboa, A Guidotti, G Pinna - Psychopharmacology, 2014 - Springer
Rationale The implications of the neurosteroid 3α-hydroxy-5α-pregnan-20-one
[allopregnanolone (Allo)] in neuropsychiatric disorders have been highlighted in several …

Therapeutical strategies for anxiety and anxiety-like disorders using plant-derived natural compounds and plant extracts

J Fedotova, P Kubatka, D Büsselberg… - Biomedicine & …, 2017 - Elsevier
Anxiety and anxiety-like disorders describe many mental disorders, yet fear is a common
overwhelming symptom often leading to depression. Currently two basic strategies are …